Request for Covid-19 Impact Assessment of this Report

Pharmaceuticals

United States Cilostazol Market Report 2017

  • QYR1274753
  • 109 Pages
  • June 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the United States Cilostazol market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Cilostazol in these regions, from 2012 to 2022 (forecast).

United States Cilostazol market competition by top manufacturers/players, with Cilostazol sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Pfizer

Teva

Otsuka Pharmaceutical

Novartis

Mylan

Squibb

Sandoz

Hikma Pharmaceuticals

GSK

Mayne Pharma

Bedford Laboratories

Abbott

Takeda

Zhejiang Weikang Pharmaceutical

Chongqing Pharscin pharmaceutical

Chengdu Leer Pharmaceutical

Yantai Yisheng Pharmaceutical

Cadila Pharmaceuticals

On the basis of product, this report displays the sales volume, revenue, product price, market share and growth rate of each type, primarily split into

Injection

Freeze-dried Powder

Oral

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Cilostazol for each application, including

Hospital

Clinic

Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Cilostazol Market Report 2017

1 Cilostazol Overview

1.1 Product Overview and Scope of Cilostazol

1.2 Classification of Cilostazol by Product Category

1.2.1 United States Cilostazol Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Cilostazol Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Injection

1.2.4 Freeze-dried Powder

1.2.5 Oral

1.3 United States Cilostazol Market by Application/End Users

1.3.1 United States Cilostazol Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 United States Cilostazol Market by Region

1.4.1 United States Cilostazol Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Cilostazol Status and Prospect (2012-2022)

1.4.3 Southwest Cilostazol Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Cilostazol Status and Prospect (2012-2022)

1.4.5 New England Cilostazol Status and Prospect (2012-2022)

1.4.6 The South Cilostazol Status and Prospect (2012-2022)

1.4.7 The Midwest Cilostazol Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Cilostazol (2012-2022)

1.5.1 United States Cilostazol Sales and Growth Rate (2012-2022)

1.5.2 United States Cilostazol Revenue and Growth Rate (2012-2022)

2 United States Cilostazol Market Competition by Players/Suppliers

2.1 United States Cilostazol Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Cilostazol Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Cilostazol Average Price by Players/Suppliers (2012-2017)

2.4 United States Cilostazol Market Competitive Situation and Trends

2.4.1 United States Cilostazol Market Concentration Rate

2.4.2 United States Cilostazol Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Cilostazol Manufacturing Base Distribution, Sales Area, Product Type

3 United States Cilostazol Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Cilostazol Sales and Market Share by Region (2012-2017)

3.2 United States Cilostazol Revenue and Market Share by Region (2012-2017)

3.3 United States Cilostazol Price by Region (2012-2017)

4 United States Cilostazol Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Cilostazol Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Cilostazol Revenue and Market Share by Type (2012-2017)

4.3 United States Cilostazol Price by Type (2012-2017)

4.4 United States Cilostazol Sales Growth Rate by Type (2012-2017)

5 United States Cilostazol Sales (Volume) by Application (2012-2017)

5.1 United States Cilostazol Sales and Market Share by Application (2012-2017)

5.2 United States Cilostazol Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Cilostazol Players/Suppliers Profiles and Sales Data

6.1 Pfizer

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Cilostazol Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Pfizer Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Teva

6.2.2 Cilostazol Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Teva Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Otsuka Pharmaceutical

6.3.2 Cilostazol Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Otsuka Pharmaceutical Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Novartis

6.4.2 Cilostazol Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Novartis Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Mylan

6.5.2 Cilostazol Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Mylan Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 Squibb

6.6.2 Cilostazol Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 Squibb Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Sandoz

6.7.2 Cilostazol Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Sandoz Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Hikma Pharmaceuticals

6.8.2 Cilostazol Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Hikma Pharmaceuticals Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 GSK

6.9.2 Cilostazol Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 GSK Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Mayne Pharma

6.10.2 Cilostazol Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Mayne Pharma Cilostazol Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Bedford Laboratories

6.12 Abbott

6.13 Takeda

6.14 Zhejiang Weikang Pharmaceutical

6.15 Chongqing Pharscin pharmaceutical

6.16 Chengdu Leer Pharmaceutical

6.17 Yantai Yisheng Pharmaceutical

6.18 Cadila Pharmaceuticals

7 Cilostazol Manufacturing Cost Analysis

7.1 Cilostazol Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Cilostazol

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Cilostazol Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Cilostazol Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Cilostazol Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Cilostazol Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Cilostazol Sales Volume Forecast by Type (2017-2022)

11.3 United States Cilostazol Sales Volume Forecast by Application (2017-2022)

11.4 United States Cilostazol Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Cilostazol

Figure United States Cilostazol Market Size (K MT) by Type (2012-2022)

Figure United States Cilostazol Sales Volume Market Share by Type (Product Category) in 2016

Figure Injection Product Picture

Figure Freeze-dried Powder Product Picture

Figure Oral Product Picture

Figure United States Cilostazol Market Size (K MT) by Application (2012-2022)

Figure United States Sales Market Share of Cilostazol by Application in 2016

Figure Hospital Examples

Table Key Downstream Customer in Hospital

Figure Clinic Examples

Table Key Downstream Customer in Clinic

Figure Others Examples

Table Key Downstream Customer in Others

Figure United States Cilostazol Market Size (Million USD) by Region (2012-2022)

Figure The West Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Cilostazol Sales (K MT) and Growth Rate (2012-2022)

Figure United States Cilostazol Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Cilostazol Market Major Players Product Sales Volume (K MT) (2012-2017)

Table United States Cilostazol Sales (K MT) of Key Players/Suppliers (2012-2017)

Table United States Cilostazol Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Cilostazol Sales Share by Players/Suppliers

Figure 2017 United States Cilostazol Sales Share by Players/Suppliers

Figure United States Cilostazol Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Cilostazol Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Cilostazol Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Cilostazol Revenue Share by Players/Suppliers

Figure 2017 United States Cilostazol Revenue Share by Players/Suppliers

Table United States Market Cilostazol Average Price (USD/MT) of Key Players/Suppliers (2012-2017)

Figure United States Market Cilostazol Average Price (USD/MT) of Key Players/Suppliers in 2016

Figure United States Cilostazol Market Share of Top 3 Players/Suppliers

Figure United States Cilostazol Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Cilostazol Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Cilostazol Product Category

Table United States Cilostazol Sales (K MT) by Region (2012-2017)

Table United States Cilostazol Sales Share by Region (2012-2017)

Figure United States Cilostazol Sales Share by Region (2012-2017)

Figure United States Cilostazol Sales Market Share by Region in 2016

Table United States Cilostazol Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Cilostazol Revenue Share by Region (2012-2017)

Figure United States Cilostazol Revenue Market Share by Region (2012-2017)

Figure United States Cilostazol Revenue Market Share by Region in 2016

Table United States Cilostazol Price (USD/MT) by Region (2012-2017)

Table United States Cilostazol Sales (K MT) by Type (2012-2017)

Table United States Cilostazol Sales Share by Type (2012-2017)

Figure United States Cilostazol Sales Share by Type (2012-2017)

Figure United States Cilostazol Sales Market Share by Type in 2016

Table United States Cilostazol Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Cilostazol Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Cilostazol by Type (2012-2017)

Figure Revenue Market Share of Cilostazol by Type in 2016

Table United States Cilostazol Price (USD/MT) by Types (2012-2017)

Figure United States Cilostazol Sales Growth Rate by Type (2012-2017)

Table United States Cilostazol Sales (K MT) by Application (2012-2017)

Table United States Cilostazol Sales Market Share by Application (2012-2017)

Figure United States Cilostazol Sales Market Share by Application (2012-2017)

Figure United States Cilostazol Sales Market Share by Application in 2016

Table United States Cilostazol Sales Growth Rate by Application (2012-2017)

Figure United States Cilostazol Sales Growth Rate by Application (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Pfizer Cilostazol Sales Growth Rate (2012-2017)

Figure Pfizer Cilostazol Sales Market Share in United States (2012-2017)

Figure Pfizer Cilostazol Revenue Market Share in United States (2012-2017)

Table Teva Basic Information List

Table Teva Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Teva Cilostazol Sales Growth Rate (2012-2017)

Figure Teva Cilostazol Sales Market Share in United States (2012-2017)

Figure Teva Cilostazol Revenue Market Share in United States (2012-2017)

Table Otsuka Pharmaceutical Basic Information List

Table Otsuka Pharmaceutical Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Otsuka Pharmaceutical Cilostazol Sales Growth Rate (2012-2017)

Figure Otsuka Pharmaceutical Cilostazol Sales Market Share in United States (2012-2017)

Figure Otsuka Pharmaceutical Cilostazol Revenue Market Share in United States (2012-2017)

Table Novartis Basic Information List

Table Novartis Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Novartis Cilostazol Sales Growth Rate (2012-2017)

Figure Novartis Cilostazol Sales Market Share in United States (2012-2017)

Figure Novartis Cilostazol Revenue Market Share in United States (2012-2017)

Table Mylan Basic Information List

Table Mylan Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Mylan Cilostazol Sales Growth Rate (2012-2017)

Figure Mylan Cilostazol Sales Market Share in United States (2012-2017)

Figure Mylan Cilostazol Revenue Market Share in United States (2012-2017)

Table Squibb Basic Information List

Table Squibb Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Squibb Cilostazol Sales Growth Rate (2012-2017)

Figure Squibb Cilostazol Sales Market Share in United States (2012-2017)

Figure Squibb Cilostazol Revenue Market Share in United States (2012-2017)

Table Sandoz Basic Information List

Table Sandoz Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Sandoz Cilostazol Sales Growth Rate (2012-2017)

Figure Sandoz Cilostazol Sales Market Share in United States (2012-2017)

Figure Sandoz Cilostazol Revenue Market Share in United States (2012-2017)

Table Hikma Pharmaceuticals Basic Information List

Table Hikma Pharmaceuticals Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Hikma Pharmaceuticals Cilostazol Sales Growth Rate (2012-2017)

Figure Hikma Pharmaceuticals Cilostazol Sales Market Share in United States (2012-2017)

Figure Hikma Pharmaceuticals Cilostazol Revenue Market Share in United States (2012-2017)

Table GSK Basic Information List

Table GSK Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure GSK Cilostazol Sales Growth Rate (2012-2017)

Figure GSK Cilostazol Sales Market Share in United States (2012-2017)

Figure GSK Cilostazol Revenue Market Share in United States (2012-2017)

Table Mayne Pharma Basic Information List

Table Mayne Pharma Cilostazol Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2012-2017)

Figure Mayne Pharma Cilostazol Sales Growth Rate (2012-2017)

Figure Mayne Pharma Cilostazol Sales Market Share in United States (2012-2017)

Figure Mayne Pharma Cilostazol Revenue Market Share in United States (2012-2017)

Table Bedford Laboratories Basic Information List

Table Abbott Basic Information List

Table Takeda Basic Information List

Table Zhejiang Weikang Pharmaceutical Basic Information List

Table Chongqing Pharscin pharmaceutical Basic Information List

Table Chengdu Leer Pharmaceutical Basic Information List

Table Yantai Yisheng Pharmaceutical Basic Information List

Table Cadila Pharmaceuticals Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Cilostazol

Figure Manufacturing Process Analysis of Cilostazol

Figure Cilostazol Industrial Chain Analysis

Table Raw Materials Sources of Cilostazol Major Players/Suppliers in 2016

Table Major Buyers of Cilostazol

Table Distributors/Traders List

Figure United States Cilostazol Sales Volume (K MT) and Growth Rate Forecast (2017-2022)

Figure United States Cilostazol Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Cilostazol Price (USD/MT) Trend Forecast (2017-2022)

Table United States Cilostazol Sales Volume (K MT) Forecast by Type (2017-2022)

Figure United States Cilostazol Sales Volume (K MT) Forecast by Type (2017-2022)

Figure United States Cilostazol Sales Volume (K MT) Forecast by Type in 2022

Table United States Cilostazol Sales Volume (K MT) Forecast by Application (2017-2022)

Figure United States Cilostazol Sales Volume (K MT) Forecast by Application (2017-2022)

Figure United States Cilostazol Sales Volume (K MT) Forecast by Application in 2022

Table United States Cilostazol Sales Volume (K MT) Forecast by Region (2017-2022)

Table United States Cilostazol Sales Volume Share Forecast by Region (2017-2022)

Figure United States Cilostazol Sales Volume Share Forecast by Region (2017-2022)

Figure United States Cilostazol Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Contact Us

+ 1-888-961-4454

Drop Us an email at

help@bigmarketresearch.com

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370